Status:

COMPLETED

Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission

Lead Sponsor:

Benha University

Conditions:

Ulcerative Colitis

Eligibility:

All Genders

20-60 years

Phase:

NA

Brief Summary

The study aimed to explore the link between parasitic infections and the severity of ulcerative colitis (UC). 120 UC patients were divided into three groups: those without infection, those with Giardi...

Eligibility Criteria

Inclusion

  • Ulcerative Colitis patients had active disease,
  • Patients had parasitic infection by G. lambellia,
  • Patients free of parasitic infection,
  • Patients free of exclusion criteria..

Exclusion

  • Patients had Inflammatory Bowel Disease other than Ulcerative Colitis,
  • Patients had multiple parasitic infections,
  • Patients had infection by parasites other than G. lambellia,
  • Patients who were maintained on immunosuppressant therapy,
  • Patients who were in remission and patients refused to sign the written consent to participate in the study.

Key Trial Info

Start Date :

September 12 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 12 2024

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06583863

Start Date

September 12 2023

End Date

June 12 2024

Last Update

September 4 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Benha faculty of Medicine

Banhā, El Qalyoubia, Egypt, 13511